Vidyya Medical News Service
*
Volume 6 Issue 361 Published - 14:00 UTC 08:00 EST 26-Dec-2004 Next Update - 14:00 UTC 08:00 EST 27-Dec-2004
little clear gif used for spacer
 
 

Abatacept and infliximab in combination with methotrexate in subjects with rheumatoid arthritis
This study is currently recruiting patients

Sponsored by: Bristol-Myers Squibb
Information provided by: Bristol-Myers Squibb

Purpose

The purpose of this clinical research study is to learn if Abatacept in combination with Methotrexate and Infliximab demonstrate a greater reduction in disease activity over placebo.

Condition Treatment or Intervention Phase
Rheumatoid Arthritis
 Drug: Abatacept
Phase III

MedlinePlus related topics:  Rheumatoid Arthritis

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control

Official Title: A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Comparative Study of Abatacept or Infliximab in Combination with Methotrexate in Controlling Disease Activity in Subjects with Rheumatoid Arthritis Having Inadequate Clinical Response to Methotrexate

Eligibility

Ages Eligible for Study:  18 Years   -   75 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Diagnosis of Rheumatoid Arthritis
  • At least 3 months prior treatment with Methotrexate (MTX)
  • At least 10 swollen joints and 12 tender joints and C-Reactive Protein of at least 1 mg/dl
  • Washout required for other disease modifying anti-rheumatic drugs (DMARDS)

Exclusion Criteria:

  • Subjects who have failed more than 3 DMARDs
  • Subjects previously treated with an approved biologic drug
  • History of cancer in the last 5 years
  • Severe or recurrent bacterial infection
  • Any previous or current medical conditions that are contraindications to the use of TNF blocking agents

Location and Contact Information

BMS Call Center      1-866-892-1BMS  Ext. 146 
BMS Call Center Outside the US and Canada      1-215-247-4079  Ext. 146 

Alabama
      Local Institution, Huntsville,  Alabama,  United States; Recruiting

Colorado
      Local Institution, Denver,  Colorado,  United States; Recruiting

Florida
      Local Institution, Boca Raton,  Florida,  United States; Recruiting

      Local Institution, Ft. Lauderdale,  Florida,  United States; Recruiting

      Local Institution, Largo,  Florida,  United States; Recruiting

Indiana
      Local Institution, Indianapolis,  Indiana,  United States; Recruiting

Louisiana
      Local Institution, New Orleans,  Louisiana,  United States; Recruiting

Massachusetts
      Local Institution, Worcester,  Massachusetts,  United States; Recruiting

      Local Institution, Springfield,  Massachusetts,  United States; Recruiting

Mississippi
      Local Institution, Flowood,  Mississippi,  United States; Recruiting

New York
      Local Institution, Syracuse,  New York,  United States; Recruiting

North Carolina
      Local Institution, Charlotte,  North Carolina,  United States; Recruiting

Ohio
      Local Institution, Cincinnati,  Ohio,  United States; Recruiting

Oklahoma
      Local Institution, Oklahoma City,  Oklahoma,  United States; Recruiting

      Local Institution, Tulsa,  Oklahoma,  United States; Recruiting

Pennsylvania
      Local Institution, Bethlehem,  Pennsylvania,  United States; Recruiting

      Local Institution, Willow Grove,  Pennsylvania,  United States; Recruiting

Texas
      Local Institution, Austin,  Texas,  United States; Recruiting

      Local Institution, Dallas,  Texas,  United States; Recruiting

Argentina
      Local Institution, Buenos Aires,  Argentina; Recruiting

      Local Institution, Cordoba,  Argentina; Recruiting

      Local Institution, Tucuman,  Argentina; Recruiting

Argentina, Buenos Aires
      Local Institution, Capital Federal,  Buenos Aires,  Argentina; Recruiting

      Local Institution, Quilmes,  Buenos Aires,  Argentina; Recruiting

Australia, Queensland
      Local Institution, Cairns,  Queensland,  Australia; Recruiting

      Local Institution, Cotton Tree,  Queensland,  Australia; Recruiting

Australia, Victoria
      Local Institution, Clayton,  Victoria,  Australia; Recruiting

      Local Institution, Heidelberg,  Victoria,  Australia; Recruiting

      Local Institution, Malvern,  Victoria,  Australia; Recruiting

      Local Institution, Parkville,  Victoria,  Australia; Recruiting

Australia, Western Australia
      Local Institution, Perth,  Western Australia,  Australia; Recruiting

Brazil
      Local Institution, Rio de Janeiro,  Brazil; Recruiting

      Local Institution, Sao Paulo,  Brazil; Recruiting

Brazil, Parana
      Local Institution, Curitiba,  Parana,  Brazil; Recruiting

Brazil, Pernambuco
      Local Institution, Recife,  Pernambuco,  Brazil; Recruiting

Brazil, Rio Grande Do Sul
      Local Institution, Porto Alegre,  Rio Grande Do Sul,  Brazil; Recruiting

Canada
      Local Institution, Kitchener,  ON,  Canada; Recruiting

Canada, Alberta
      Local Institution, Calgary,  Alberta,  Canada; Recruiting

      Local Institution, Edmonton,  Alberta,  Canada; Recruiting

Canada, Manitoba
      Local Institution, Winnipeg,  Manitoba,  Canada; Recruiting

Canada, Newfoundland and Labrador
      Local Institution, St. Johns,  Newfoundland and Labrador,  Canada; Recruiting

Canada, Ontario
      Local Institution, Hamilton,  Ontario,  Canada; Recruiting

      Local Institution, Ottawa,  Ontario,  Canada; Recruiting

Canada, Quebec
      Local Institution, Montreal,  Quebec,  Canada; Recruiting

      Local Institution, Ste Foy,  Quebec,  Canada; Recruiting

Canada, Saskatchewan
      Local Institution, Saskatoon,  Saskatchewan,  Canada; Recruiting

Czech Republic
      Local Institution, PRAGUE 2,  Czech Republic; Recruiting

Denmark
      Local Institution, Copenhagen,  Denmark; Recruiting

      Local Institution, Copenhagen Nv,  Denmark; Recruiting

Korea, Republic of
      Local Institution, Seoul,  Korea, Republic of; Recruiting

Mexico
      Local Institution, San Luis Potosi,  Mexico; Recruiting

Mexico, Baja California
      Local Institution, Tijuana,  Baja California,  Mexico; Recruiting

Mexico, Distrito Federal
      Local Institution, Mexico,  Distrito Federal,  Mexico; Recruiting

Mexico, Guanajuato
      Local Institution, Leon,  Guanajuato,  Mexico; Recruiting

Mexico, Jalisco
      Local Institution, Guadalajara,  Jalisco,  Mexico; Recruiting

Mexico, Nuevo Leon
      Local Institution, Monterrey,  Nuevo Leon,  Mexico; Recruiting

Peru
      Local Institution, Lima,  Peru; Recruiting

Poland
      Local Institution, Poznan,  Poland; Recruiting

      Local Institution, Sopot,  Poland; Recruiting

      Local Institution, Warszawa,  Poland; Recruiting

Puerto Rico
      Local Institution, San Juan,  Puerto Rico; Recruiting

Russian Federation
      Local Institution, Moscow,  Russian Federation; Recruiting

South Africa, Gauteng
      Local Institution, Muckleneuk,  Gauteng,  South Africa; Recruiting

South Africa, Kwa Zulu Natal
      Local Institution, Berea,  Kwa Zulu Natal,  South Africa; Recruiting

South Africa, Western Cape
      Local Institution, Panorama,  Western Cape,  South Africa; Recruiting

Spain
      Local Institution, A Coruna,  Spain; Recruiting

      Local Institution, Barcelona,  Spain; Recruiting

      Local Institution, Cordoba,  Spain; Recruiting

      Local Institution, Madrid,  Spain; Recruiting

Sweden
      Local Institution, FALUN,  Sweden; Recruiting

      Local Institution, Huddinge,  Sweden; Recruiting

      Local Institution, Linkoping,  Sweden; Recruiting

      Local Institution, Lund,  Sweden; Recruiting

      Local Institution, Stockholm,  Sweden; Recruiting

      Local Institution, Uppsala,  Sweden; Recruiting

Switzerland
      Local Institution, Bern,  Switzerland; Recruiting

      Local Institution, St. Gallen,  Switzerland; Recruiting

More Information

Study ID Numbers:  IM101-043
Record last reviewed:  December 2004
Record first received:  November 1, 2004
ClinicalTrials.gov Identifier:  NCT00095147
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-12-23

© RAmEx Ars Medica, Inc.
 
 

  More Today in Vidyya